In addition, the treatment of HCC cells with EGFR-specific tyrosine kinase inhibitors or neutralizing antibodies induces cell cycle arrest and apoptosis and increases chemosensitivity [41,42]. This evidence concerns the gene EGFR and hepatocellular carcinoma.